- Johnson & Johnson (JNJ) has become the latest major pharmaceutical firm to say that it will make more data from its clinical trials available to researchers.
- JNJ has signed an agreement with Yale University to share information about hundreds of drugs and other products.
- Yale will vet requests from researchers without input from J&J.
- Part of the idea is to increase the credibility of the data. "The medical scientific community and population at large want to have more transparency on what we do," says J&J's Paul Stoffels. "To get really credible, we took the leap."
- Other big pharma companies to pledge to release data in the past year include GSK and Roche. (PR)
J&J to share trial data via agreement with Yale
From other sites
at 4-traders.com (Tue, 12:37PM)
at Nasdaq.com (Mar 16, 2015)
at Nasdaq.com (Mar 11, 2015)
at Benzinga.com (Feb 23, 2015)
at Nasdaq.com (Feb 19, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs